Dynamic42’s organ models will support your vision of human-relevant research, for better clinical outcomes and disease insights that matter, while minimizing the impact on animals.
Since spring 2025, Ohio Lumex has been the exclusive distributor of Dynamic42 products in the U.S. and Canada. This partnership has significantly streamlined access for pharmaceutical companies, universities, and biotech startups across North America to test drugs and study disease mechanisms using real human tissue environments. Dynamic42’s organ-on-a-chip technology offers dynamic flow conditions and can model multiple organ systems, delivering powerful insights into drug responses, toxicity, and disease pathology—without the use of lab animals.
It’s a technology that replicates human organ biology on a small-scale biochip, mimicking key functions and responses to provide human-relevant data for preclinical drug testing and biomedical research.
| 2D Cell Culture | Spheroids | Organoids | Animal Models | Organ-on-Chip | |
|---|---|---|---|---|---|
|
Human relevance of data |
|
|
|
|
|
|
3D organs/tissues |
|
|
|
|
|
|
Cellular diversity |
|
|
|
|
|
|
Immune component |
|
|
|
|
|
|
Molecular gradients |
|
|
|
|
|
|
Microbiome/pathogens |
|
|
|
|
|
|
(Blood) flow/perfusion |
|
|
|
|
|
|
Max. culture time |
~4 Weeks |
~4 Weeks |
~4 Weeks |
Months |
2 – 4 Weeks |
|
Throughput |
High |
High |
Medium to High |
Low |
Low to Medium |
|
Time to result |
Fast |
Fast |
Medium |
Slow |
Medium |
|
Cost |
Low |
Medium |
Medium |
High |
Medium |
|
Effort of model set up |
Low |
Low |
Medium |
High |
Medium |
